Intravenous immunoglobulin therapy for autoimmune diseases.
about
Effects of chalcone derivatives on players of the immune systemDesensitization for solid organ and hematopoietic stem cell transplantationAnalysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionationA differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms.Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo.Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN.Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patientsIndications and safety of intravenous and subcutaneous immunoglobulin therapy.Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.Regaining tolerance to a self-antigen by the modified vaccination technique.Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats.Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells?Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.Anti-serum with anti-autoantibody activity decreases autoantibody-positive B lymphocytes and type 1 diabetes of female NOD mice.Epitope predictions indicate the presence of two distinct types of epitope-antibody-reactivities determined by epitope profiling of intravenous immunoglobulins.Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.Limbic encephalitis and related cortical syndromes.
P2860
Q26796454-D25402A4-2433-40C0-908D-B741BC81E6EEQ26863564-CAEB0BDC-270F-47BD-97DB-3A774694026FQ28728886-E4ACFDA6-C5BA-4569-AF78-D2AB9F414C27Q31040502-6C0A9712-A8CC-4617-BED4-567B8679D102Q33399238-CDCDC6E0-6073-404C-AAF1-DFDA75BDC16CQ33409741-BB144FEB-37EF-466A-BFBB-414D2BEBF9D2Q33419269-0DFEF4BD-1BB4-4DB3-A0FC-D156A86126BFQ33427260-FCFDA079-8D5C-43A7-ACB3-104D63BB3D71Q36113220-0AF88A22-C609-4B04-8369-CE502A498908Q36500575-F2373D14-58A4-4862-B87F-0DD0479C0E32Q36506677-02CCA94A-63ED-4593-BA9A-8B67BD214215Q37698474-1E0DD722-355E-418B-A115-5ACDA9F51F04Q37732919-95678113-595C-4553-B84F-7BB56B00A266Q37877259-2CB7BC7F-FF14-45E4-A8D3-EF51F06CCB09Q38027890-32DD4527-2D43-4A71-AC33-78E547E0C588Q38072388-7070F208-5096-40AB-8DB0-A40D449A1CCDQ38931847-26245519-6219-4A3F-9676-18C5477002ADQ39447037-045633E0-7D32-4A77-AD68-2A4B06F204E0Q39729881-1F982EE1-302A-414F-A1C5-C4370D4A3D2AQ41428260-78691C0E-DD59-4C1C-B445-97DB89CFBA45Q42913211-63FC703F-BBBF-43FC-B8E9-E690C4B14BD2Q43736626-3C77D0E1-091C-4B00-9B19-9DA80C5CC391Q44187530-098BEB85-BF98-45EA-A3B7-70E454C162AE
P2860
Intravenous immunoglobulin therapy for autoimmune diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravenous immunoglobulin therapy for autoimmune diseases.
@en
Intravenous immunoglobulin therapy for autoimmune diseases.
@nl
type
label
Intravenous immunoglobulin therapy for autoimmune diseases.
@en
Intravenous immunoglobulin therapy for autoimmune diseases.
@nl
prefLabel
Intravenous immunoglobulin therapy for autoimmune diseases.
@en
Intravenous immunoglobulin therapy for autoimmune diseases.
@nl
P2860
P50
P1433
P1476
Intravenous immunoglobulin therapy for autoimmune diseases.
@en
P2860
P304
P356
10.1080/08916930902785363
P577
2009-09-01T00:00:00Z